These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9889964)

  • 21. Role of G-protein-coupled signaling in the induction and regulation of dendritic cell function by Toxoplasma gondii.
    Aliberti J; Sher A
    Microbes Infect; 2002 Jul; 4(9):991-7. PubMed ID: 12106793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Innate resistance against Toxoplasma gondii: an evolutionary tale of mice, cats, and men.
    Gazzinelli RT; Mendonça-Neto R; Lilue J; Howard J; Sher A
    Cell Host Microbe; 2014 Feb; 15(2):132-8. PubMed ID: 24528860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-23 provides a limited mechanism of resistance to acute toxoplasmosis in the absence of IL-12.
    Lieberman LA; Cardillo F; Owyang AM; Rennick DM; Cua DJ; Kastelein RA; Hunter CA
    J Immunol; 2004 Aug; 173(3):1887-93. PubMed ID: 15265921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Absence of mitogen-activated protein kinase family member c-Jun N-terminal kinase-2 enhances resistance to Toxoplasma gondii.
    Sukhumavasi W; Warren AL; Del Rio L; Denkers EY
    Exp Parasitol; 2010 Nov; 126(3):415-20. PubMed ID: 20117109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parasite-induced lipoxin A4 is an endogenous regulator of IL-12 production and immunopathology in Toxoplasma gondii infection.
    Aliberti J; Serhan C; Sher A
    J Exp Med; 2002 Nov; 196(9):1253-62. PubMed ID: 12417634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA vaccine ROP29 from Toxoplasma gondii containing R848 enhances protective immunity in mice.
    Lu G; Zhou J; Zhao YH; Wang L
    Parasite Immunol; 2018 Oct; 40(10):e12578. PubMed ID: 30091162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytokines, Toxoplasma and intracellular parasitism.
    Beaman MH; Wong SY; Remington JS
    Immunol Rev; 1992 Jun; 127():97-117. PubMed ID: 1506009
    [No Abstract]   [Full Text] [Related]  

  • 28. From cells to signaling cascades: manipulation of innate immunity by Toxoplasma gondii.
    Denkers EY
    FEMS Immunol Med Microbiol; 2003 Dec; 39(3):193-203. PubMed ID: 14642303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional inactivation of immature dendritic cells by the intracellular parasite Toxoplasma gondii.
    McKee AS; Dzierszinski F; Boes M; Roos DS; Pearce EJ
    J Immunol; 2004 Aug; 173(4):2632-40. PubMed ID: 15294980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conditioning of dendritic cells by pathogen-derived stimuli.
    Reis e Sousa C; Edwards AD; Manickasingham SP; Schulz O
    Immunobiology; 2001 Dec; 204(5):595-7. PubMed ID: 11846223
    [No Abstract]   [Full Text] [Related]  

  • 31. Vaccination concepts against Toxoplasma gondii.
    Garcia JL
    Expert Rev Vaccines; 2009 Feb; 8(2):215-25. PubMed ID: 19196201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toll road for Toxoplasma gondii: the mystery continues.
    Khan IA
    Trends Parasitol; 2007 Jan; 23(1):1-3. PubMed ID: 17084106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Host immune responses to Toxoplasma gondii.
    Sasai M; Pradipta A; Yamamoto M
    Int Immunol; 2018 Mar; 30(3):113-119. PubMed ID: 29408976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TGF-β in Toxoplasmosis: Friend or foe?
    Zare-Bidaki M; Assar S; Hakimi H; Abdollahi SH; Nosratabadi R; Kennedy D; Arababadi MK
    Cytokine; 2016 Oct; 86():29-35. PubMed ID: 27449809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parasite Manipulation of the Invariant Chain and the Peptide Editor H2-DM Affects Major Histocompatibility Complex Class II Antigen Presentation during Toxoplasma gondii Infection.
    Leroux LP; Nishi M; El-Hage S; Fox BA; Bzik DJ; Dzierszinski FS
    Infect Immun; 2015 Oct; 83(10):3865-80. PubMed ID: 26195549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BALB/c mice resistant to Toxoplasma gondii infection proved to be highly susceptible when previously infected with Myocoptes musculinus fur mites.
    Welter A; Mineo JR; de Oliveira Silva DA; Lourenço EV; Vieira Ferro EA; Roque-Barreira MC; Maria da Silva N
    Int J Exp Pathol; 2007 Oct; 88(5):325-35. PubMed ID: 17877534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toxoplasma gondii antigen-pulsed-dendritic cell-derived exosomes induce a protective immune response against T. gondii infection.
    Aline F; Bout D; Amigorena S; Roingeard P; Dimier-Poisson I
    Infect Immun; 2004 Jul; 72(7):4127-37. PubMed ID: 15213158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Progress of CD8+ T cell-mediated immune response to Toxoplasma gondii infection].
    Wu B; Lyu FL
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2014 Apr; 32(2):143-7. PubMed ID: 25065216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Class I major histocompatibility complex presentation of antigens that escape from the parasitophorous vacuole of Toxoplasma gondii.
    Gubbels MJ; Striepen B; Shastri N; Turkoz M; Robey EA
    Infect Immun; 2005 Feb; 73(2):703-11. PubMed ID: 15664908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Rudolf-Virchow Prize 1998. Award lecture. Toxoplasmosis: a model infection for studying systemic and intracerebral immune reactions].
    Deckert-Schlüter M
    Verh Dtsch Ges Pathol; 1998; 82():9-22. PubMed ID: 10095413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.